3177 results for «397»
3177 results
What does the interventionist need to know from the imager?
21 Nov 2023 – From PCR London Valves 2023
Take inspiration from the discussions on the case of a 78-year-old patient with HTN, HLD, and AF, presenting with symptomatic heart failure, or that of a 59-year-old female patient, former smoker, with HTN, DM, and persistent AF, who had been treated for breast carcinoma and post-chemotherapy...
PCR London Valves 2023 Welcome Ceremony
19 Nov 2023 – From PCR London Valves 2023
Experience the emotion of the opening ceremony of this 2023 edition of the PCR London Valves Course, which kicks off a rich 3-day programme from every point of view, and listen to the Course Directors announce the highlights and new features.
PCR London Valves 2023 EAPCI Awards Ceremony
21 Nov 2023 – From PCR London Valves 2023
Discover the winners of the EAPCI Awards in this ceremony jointly presented by Emanuele Barbato, EAPCI President, and Tanja Rudolph, Co-Chair of the EAPCI Fellowship Grants Committee. While 14 nominees were shortlisted, seven had already been honored at EuroPCR 2023: Find out who the lucky winners...
Key questions in tricuspid valve intervention - How do I define treatment options according to individual patient anatomy?
19 Nov 2023 – From PCR London Valves 2023
Explore this tricuspid valve-focused session featuring analysis of four clinical cases: Ebstein anomaly, severe and torrential tricuspid regurgitations, and anterior flail-related torrential regurgitation. Gain insights into optimal treatment selection for each scenario, leveraging pre-procedural imaging for informed decision-making.
Don't forget the nurses and allied professionals when introducing new technology!
19 Nov 2023 – From PCR London Valves 2023
Learn all you need to know about adopting new technology, bearing in mind that both trainer and trainee share learning responsibilities and that focus should be on collaboration with industry and variety of teaching methods.
Key questions in tricuspid valve intervention - How does the role of the right heart and pulmonary vasculature influence patient selection?
19 Nov 2023 – From PCR London Valves 2023
Explore insights from an 86-year-old female patient's case with TAVR since end-2022 who presented with permanent AF, moderate MR and TR regurgitation, and learn more about right heart catheterisation for patient selection, CT and CMR in tricuspid interventions, criteria for atrial secondary TR, and more!
Key questions in aortic valve intervention - What are the surgical and transcatheter treatment options for patients with severe aortic regurgitation?
21 Nov 2023 – From PCR London Valves 2023
Although aortic regurgitation is highly prevalent, it remains under-diagnosed and under-treated. Fortunately, the latest devices should rapidly reverse this trend, both surgically and through transcatheter treatments. Find out more about the options available today, whether surgical or transcatheter, with their benefits and limitations, and how to choose them...
Mitral valve intervention in complex scenarios - Valve-in-valve, valve-in-ring, valve-in-MAC
21 Nov 2023 – From PCR London Valves 2023
What role does imaging play in complex mitral interventions such as valve-in-valve, valve-in-ring or valve-in-MAC? Study how CT-scan, fusion imaging, TEE and TOE are used throughout the procedures and analyse the latest trial results on the subject to get an idea.
Second time TAVI (TAV-in-TAV) - Not as simple as it looks
19 Nov 2023 – From PCR London Valves 2023
Although it is still rare, TAV-in-TAV is likely to become more frequent, as TAVI is increasingly implanted in younger patients. Harmonizing data in this area will therefore help to improve outcomes, the quality of which depends on site experience, bearing in mind that for the time...
The aortic regurgitation problem: an imaging and practical perspective
02 Feb 2024 – From PCR Imaging Valves Madrid 2024
In this session, discover strategies to address biases in aortic regurgitation, influenced by factors like etiology, natural history, surgical risk, age, and gender, and explore an imaging-centric approach to better quantify aortic regurgitation and comprehend its relationship with left ventricular remodeling and outcomes. Anticipate forthcoming guidelines...
TAVI essentials: anatomical factors, prosthesis selection, and complication management
02 Feb 2024 – From PCR Imaging Valves Madrid 2024
Discover a comprehensive exploration of critical considerations in TAVI in this section. From anatomical factors guiding the choice between TAVI and SAVR to strategies for selecting the optimal TAVI prosthesis for individual patients, each topic offers essential insights. Gain valuable insights into navigating TAVI for bicuspid...
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial
07 Nov 2022
Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation.
Author
IMPELLA supported PCI via a single access sheath - Introduction and rapid adoption: the Power of Social Media
22 Dec 2020
This manuscript examines Impella single access technique, which provides a case example of the central role social media can play in the introduction of a new interventional approach.
RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation
05 Sep 2023
Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.
Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...
Author
The Lancet Commission to reduce global burden of cardiovascular disease in women by 2030
29 Aug 2021
Vijay Kunadian summarizes the key points of the LBT session of the ESC congress 2021 held on Sunday, 29 August focusing on the Lancet Commission to reduce the global burden of heart disease in women by 2030.
Author
Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques (PREVENT)
08 Apr 2024
Ali Nazmi Calik provides his take on the results of the PREVENT trial presented at ACC.24 in Atlanta.
Author
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation
05 Sep 2023
The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...
Author
Author
